Keyphrases
Peruvian
100%
Sofosbuvir
100%
Direct-acting Antiviral Drugs
100%
Ledipasvir
100%
Sustained Viral Response
75%
Direct-acting Antivirals
50%
Simeprevir
50%
Peru
25%
Public Health
25%
Statistical Analysis
25%
Treatment Strategy
25%
Serious Adverse Events
25%
Cirrhosis
25%
Hepatitis C
25%
Patients Included
25%
Genotype 1
25%
Chronic Hepatitis C
25%
Non-responders
25%
Ribavirin
25%
Real-world Experience
25%
Antiviral Treatment
25%
Hepatologist
25%
Digital Survey
25%
Medicine and Dentistry
Antivirus Agent
100%
Ledipasvir Plus Sofosbuvir
100%
Sofosbuvir
33%
Simeprevir
33%
Public Health
16%
Adverse Event
16%
Liver Cirrhosis
16%
Hepatitis C
16%
Personal Experience
16%
Antiviral Therapy
16%
Ribavirin
16%
Chronic Hepatitis C
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Ledipasvir Plus Sofosbuvir
100%
Simeprevir
33%
Sofosbuvir
33%
Adverse Event
16%
Hepatitis C
16%
Liver Cirrhosis
16%
Ribavirin
16%
Chronic Hepatitis C
16%